|
"kang yi su"的相關文件
顯示項目 66-85 / 85 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T15:35:59Z |
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms
|
Chang, W.-H.; Su, K.-Y.; Ku, W.-H.; Chang, G.-C.; Hong, Q.-S.; Hsiao, Y.-J.; Chen, H.-C.; Chen, H.-Y.; Wu, R.; Yang, P.-C.; Chen, J.J.W.; Yu, S.-L.; Chen, C.-H.; SUNG-LIANG YU; KANG-YI SU; 楊泮池et al. |
| 臺大學術典藏 |
2018-09-10T15:33:32Z |
Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients
|
Liu, Chien-Ming; Yang, Pan-Chyr; Chen, Jeremy J. W.; Chang, Gee-Chen; ?????; Wu, Ming-Fang; Chiu, Kuo-Liang; Hsia, Te-Chun; Ho, Chao-Chi; Yu, Chong-Jen; Su, Kang-Yi; Yang, Cheng-Ta; Yu, Sung-Liang; Tsai, Chi-Ren; Chen, Hsuan-Yu; Chen, Kun-Chieh; Hsu, K.-H. and Tseng, J.-S. and Wang, C.-L. and Yang, T.-Y. and Tseng, C.-H. and Chen, H.-Y. and Chen, K.-C. and Tsai, C.-R. and Yang, C.-T. and Yu, S.-L. and Su, K.-Y. and Yu, C.-J. and Ho, C.C. and Hsia, T.-C. and Wu, M.-F. and Chiu, K.-L. and Liu, C.-M. and Yang, P.-C. and Chen, J.J.W. and Chang, G.-C.; Hsu, Kuo-Hsuan;Tseng, Jeng-Sen;Wang, Chih-Liang;Yang, Tsung-Ying;Tseng, Chien-Hua;Chen, Hsuan-Yu;Chen, Kun-Chieh;Tsai, Chi-Ren;Yang, Cheng-Ta;Yu, Sung-Liang;Su, Kang-Yi;Yu, Chong-Jen;Ho, Chao-Chi;Hsia, Te-Chun;Wu, Ming-Fang;Chiu, Kuo-Liang;Liu, Chien-Ming;Yang, Pan-Chyr;Chen, Jeremy J. W.;Chang, Gee-Chen; Hsu, Kuo-Hsuan;Tseng, Jeng-Sen;Wang, Chih-Liang;Yang, Tsung-Ying;Tseng, Chien-Hua;Chen, Hsuan-Yu;Chen, Kun-Chieh;Tsai, Chi-Ren;Yang, Cheng-Ta;Yu, Sung-Liang;Su, Kang-Yi;Yu, Chong-Jen;Ho, Chao-Chi;Hsia, Te-Chun;Wu, Ming-Fang;Chiu, Kuo-Liang;Liu, Chien-Ming;Yang, Pan-Chyr;Chen, Jeremy J. W.;Chang, Gee-Chen; 俞松良;蘇剛毅;楊泮池;余忠仁;何肇基; 俞松良;蘇剛毅;楊泮池;余忠仁;何肇基; SUNG-LIANG YU; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; CHONG-JEN YU; Wang, Chih-Liang; KANG-YI SU; CHAO-CHI HO; Yang, Tsung-Ying; Tseng, Chien-Hua |
| 臺大學術典藏 |
2018-09-10T15:33:32Z |
Implementation and Quality Control of Lung Cancer EGFR Genetic Testing by MALDI-TOF Mass Spectrometry in Taiwan Clinical Practice
|
Su, K.-Y. and Kao, J.-T. and Ho, B.-C. and Chen, H.-Y. and Chang, G.-C. and Ho, C.-C. and Yu, S.-L.; Su, Kang-Yi;Kao, Jau-Tsuen;Ho, Bing-Ching;Chen, Hsuan-Yu;Chang, Gee-Cheng;Ho, Chao-Chi;Yu, Sung-Liang; 何炳慶;俞松良;蘇剛毅;高照村;何肇基; SUNG-LIANG YU; Su, Kang-Yi; Su, Kang-Yi; Kao, Jau-Tsuen; KANG-YI SU; Kao, Jau-Tsuen; Ho, Bing-Ching; CHAO-CHI HO; Ho, Bing-Ching; Chen, Hsuan-Yu; Chen, Hsuan-Yu; JAU-TSUEN KAO; Chang, Gee-Cheng; Ho, Chao-Chi; Ho, Chao-Chi; Yu, Sung-Liang; Yu, Sung-Liang; Chang, Shan-Chwen |
| 臺大學術典藏 |
2018-09-10T15:27:22Z |
Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan
|
Hsu, Kuo-Hsuan;Ho, Chao-Chi;Hsia, Te-Chun;Tseng, Jeng-Sen;Su, Kang-Yi;Wu, Ming-Fang;Chiu, Kuo-Liang;Yang, Tsung-Ying;Chen, Kun-Chieh;Ooi, Hean;Wu, Tzu-Chin;Chen, Hung-Jen;Chen, Hsuan-Yu;Chang, Chi-Sheng;Hsu, Chung-Ping;Hsia, Jiun-Yi;Chuang, Cheng-Yen;Lin, Chin-Hung;Chen, Jeremy J. W.;Chen, Kuan-Yu;Liao, Wei-Yu;Shih, Jin-Yuan;Yu, Sung-Liang;Yu, Chong-Jen;Yang, Pan-Chyr;Chang, Gee-Chen; Hsu, K.-H. and Ho, C.-C. and Hsia, T.-C. and Tseng, J.-S. and Su, K.-Y. and Wu, M.-F. and Chiu, K.-L. and Yang, T.-Y. and Chen, K.-C. and Ooi, H. and Wu, T.-C. and Chen, H.-J. and Chen, H.-Y. and Chang, C.-S. and Hsu, C.-P. and Hsia, J.-Y. and Chuang, C.-Y. and Lin, C.-H. and Chen, J.J.W. and Chen, K.-Y. and Liao, W.-Y. and Shih, J.-Y. and Yu, S.-L. and Yu, C.-J. and Yang, P.-C. and Chang, G.-C.; 俞松良;蘇剛毅;楊泮池;廖唯昱;陳冠宇;余忠仁;何肇基;施金元; Hsu, Kuo-Hsuan; SUNG-LIANG YU; Ho, Chao-Chi; Chong-Jen Yu; Hsia, Te-Chun; WEI-YU LIAO; Tseng, Jeng-Sen; KANG-YI SU; JIN-YUAN SHIH; Su, Kang-Yi; Wu, Ming-Fang; Chiu, Kuo-Liang; Yang, Tsung-Ying; Chen, Kun-Chieh; Ooi, Hean; Wu, Tzu-Chin; Chen, Hung-Jen; Chen, Hsuan-Yu; Chang, Chi-Sheng; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung; Chen, Jeremy J. W.; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Sung-Liang; Yu, Chong-Jen; Yang, Pan-Chyr; Chang, Gee-Chen |
| 臺大學術典藏 |
2018-09-10T15:24:44Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Ho, Chao-Chi; Hsia, Te-Chun; Su, Kang-Yi; Wu, Ming-Fang; Chiu, Kuo-Liang; Liu, Chien-Ming; Wu, Tzu-Chin; Chen, Hung-Jen; Chen, Hsuan-Yu; Chang, Chi-Sheng; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung; Chen, Jeremy J. W.; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Sung-Liang; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, Tsung-Ying; Chang, Gee-Chen; Tseng, Chien-Hua; 楊泮池; SUNG-LIANG YU; WEI-YU LIAO; CHONG-JEN YU; KANG-YI SU; CHAO-CHI HO; JIN-YUAN SHIH; Yang, Pan-Chyret al. |
| 臺大學術典藏 |
2018-09-10T14:58:38Z |
Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer
|
Chen, Chun-Chieh;Chen, Hsuan-Yu;Su, Kang-Yi;Hong, Qi-Sheng;Yan, Bo-Shiun;Chen, Ching-Hsien;Pan, Szu-Hua;Chang, Yih-Leong;Wang, Chia-Jen;Hung, Pei-Fang;Yuan, Shinsheng;Chang, Gee-Chen;Chen, Jeremy J. W.;Yang, Pan-Chyr;Yang, Ya-Chien;Yu, Sung-Liang; Chen, C.-C. and Chen, H.-Y. and Su, K.-Y. and Hong, Q.-S. and Yan, B.-S. and Chen, C.-H. and Pan, S.-H. and Chang, Y.-L. and Wang, C.-J. and Hung, P.-F. and Yuan, S. and Chang, G.-C. and Chen, J.J.W. and Yang, P.-C. and Yang, Y.-C. and Yu, S.-L.; 俞松良;楊雅倩;張逸良;楊泮池;顏伯勳;潘思樺; SUNG-LIANG YU; Chen, Chun-Chieh; YIH-LEONG CHANG; Chen, Hsuan-Yu; YA-CHIEN YANG; Su, Kang-Yi; Su, Kang-Yi; Hong, Qi-Sheng; KANG-YI SU; Yan, Bo-Shiun; Yan, Bo-Shiun; Chen, Ching-Hsien; Pan, Szu-Hua; Pan, Szu-Hua; Chang, Yih-Leong; Chang, Yih-Leong; Wang, Chia-Jen; Hung, Pei-Fang; Yuan, Shinsheng; Chang, Gee-Chen; Chen, Jeremy J. W.; Chen, Jeremy J. W.; Yang, Pan-Chyr; Yang, Pan-Chyr; Yang, Ya-Chien; Yu, Sung-Liang; Yu, Sung-Liang; 楊泮池 |
| 臺大學術典藏 |
2018-09-10T14:49:40Z |
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma
|
Tseng, Jeng-Sen;Yang, Tsung-Ying;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Yu, Chong-Jen;Liao, Wei-Yu;Tsai, Chi-Ren;Tsai, Meen-Hsin;Yu, Sung-Liang;Su, Kang-Yi;Chen, Jeremy J. W.;Chen, Hsuan-Yu;Chang, Gee-Chen; Tseng, J.-S. and Yang, T.-Y. and Chen, K.-C. and Hsu, K.-H. and Yu, C.-J. and Liao, W.-Y. and Tsai, C.-R. and Tsai, M.-H. and Yu, S.-L. and Su, K.-Y. and Chen, J.J.W. and Chen, H.-Y. and Chang, G.-C.; 俞松良;蘇剛毅;廖唯昱;余忠仁; SUNG-LIANG YU; Tseng, Jeng-Sen; Tseng, Jeng-Sen; CHONG-JEN YU; Yang, Tsung-Ying; Yang, Tsung-Ying; Chen, Kun-Chieh; WEI-YU LIAO; Hsu, Kuo-Hsuan; KANG-YI SU; Yu, Chong-Jen; Yu, Chong-Jen; Liao, Wei-Yu; Liao, Wei-Yu; Tsai, Chi-Ren; Tsai, Meen-Hsin; Yu, Sung-Liang; Yu, Sung-Liang; Su, Kang-Yi; Su, Kang-Yi; Chen, Jeremy J. W.; Chen, Jeremy J. W.; Chen, Hsuan-Yu; Chen, Hsuan-Yu; Chang, Gee-Chen |
| 臺大學術典藏 |
2018-09-10T09:13:24Z |
Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice
|
Hsu, Yu-Chen;Huang, Hsiang-Po;Yu, I-Shing;Su, Kang-Yi;Lin, Shu-Rung;Lin, Wei-Chou;Wu, Hua-Lin;Shi, Guey-Yueh;Tao, Mi-Hua;Kao, Cheng-Heng;Wu, Yao-Ming;Martin, Patricia E.;Lin, Shih-Yao;Yang, Pan-Chyr;Lin, Shu-Wha; Hsu, Yu-Chen;Huang, Hsiang-Po;Yu, I-Shing;Su, Kang-Yi;Lin, Shu-Rung;Lin, Wei-Chou;Wu, Hua-Lin;Shi, Guey-Yueh;Tao, Mi-Hua;Kao, Cheng-Heng;Wu, Yao-Ming;Martin, Patricia E.;Lin, Shih-Yao;Yang, Pan-Chyr;Lin, Shu-Wha; Hsu, Y.-C. and Huang, H.-P. and Yu, I.-S. and Su, K.-Y. and Lin, S.-R. and Lin, W.-C. and Wu, H.-L. and Shi, G.-Y. and Tao, M.-H. and Kao, C.-H. and Wu, Y.-M. and Martin, P.E. and Lin, S.-Y. and Yang, P.-C. and Lin, S.-W.; 楊泮池 ;林維洲 ;林淑華 ;黃祥博 ;吳耀銘; 楊泮池 ;林維洲 ;林淑華 ;黃祥博 ;吳耀銘; 楊泮池; Hsu, Yu-Chen; HSIANG-PO HUANG; Hsu, Yu-Chen; Huang, Hsiang-Po; Huang, Hsiang-Po; KANG-YI SU; Yu, I-Shing; Yu, I-Shing; WEI-CHOU LIN; Su, Kang-Yi; Su, Kang-Yi; YAO-MING WU; SHU-WHA LIN; Lin, Shu-Rung; Lin, Shu-Rung; Lin, Wei-Chou; Lin, Wei-Chou; Wu, Hua-Lin; Wu, Hua-Lin; Shi, Guey-Yueh; Tao, Mi-Hua; Tao, Mi-Hua; Kao, Cheng-Heng; Kao, Cheng-Heng; Wu, Yao-Ming; Wu, Yao-Ming; Martin, Patricia E.; Martin, Patricia E.; Lin, Shih-Yao; Lin, Shih-Yao; Yang, Pan-Chyr; Yang, Pan-Chyr; Lin, Shu-Wha; Lin, Shu-Wha |
| 臺大學術典藏 |
2018-09-10T09:13:23Z |
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
|
Tsai, T.-H. and Su, K.-Y. and Wu, S.-G. and Chang, Y.-L. and Luo, S.-C. and Jane, I.-S. and Yu, C.-J. and Yue, S.-L. and Shih, J.-Y. and Yang, P.-C.; Tsai, T-H.;Su, K-Y.;Wu, S-G.;Chang, Y-L.;Luo, S-C.;Jan, I-S.;Yu, C-J.;Yu, S-L.;Shih, J-Y.;Yang, P-C.; 俞松良 ;詹一秀 ;張逸良 ;楊泮池 ;余忠仁 ;吳尚俊 ;蔡子修 ;施金元; Tsai, T-H.; YIH-LEONG CHANG; Tsai, T-H.; Chong-Jen Yu; Su, K-Y.; Wu, S-G.; Wu, S-G.; KANG-YI SU; JIN-YUAN SHIH; Chang, Y-L.; Luo, S-C.; Luo, S-C.; Jan, I-S.; Jan, I-S.; Yu, C-J.; Yu, S-L.; Shih, J-Y.; Shih, J-Y.; Yang, P-C.; 楊泮池 |
| 臺大學術典藏 |
2018-09-10T08:30:30Z |
Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E
|
Ho, B.-C. and Yu, S.-L. and Chen, J.J.W. and Chang, S.-Y. and Yan, B.-S. and Hong, Q.-S. and Singh, S. and Kao, C.-L. and Chen, H.-Y. and Su, K.-Y. and Li, K.-C. and Cheng, C.-L. and Cheng, H.-W. and Lee, J.-Y. and Lee, C.-N. and Yang, P.-C.; SUI-YUAN CHANG; SUNG-LIANG YU; BO-SHIUN YAN; KANG-YI SU; CHUAN-LIANG KAO |
| 臺大學術典藏 |
2018-09-10T08:29:24Z |
Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor
|
KANG-YI SU; JIN-YUAN SHIH; Chang, T.-H. and Tsai, M.-F. and Su, K.-Y. and Wu, S.-G. and Huang, C.-P. and Yu, S.-L. and Yu, Y.-L. and Lan, C.-C. and Yang, C.-H. and Lin, S.-B. and Wu, C.-P. and Shih, J.-Y. and Yang, P.-C.; SUNG-LIANG YU |
| 臺大學術典藏 |
2018-09-10T08:28:50Z |
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations
|
Chang, Yih-Leong; Cheng, Chiou-Ling; Hsu, Chung-Ping; Hsia, Jiun-Yi; Lin, Chien-Yu; Wu, Guani; Yuan, S. and Yu, S.-L. and Chen, H.-Y. and Hsu, Y.-C. and Su, K.-Y. and Chen, H.-W. and Chen, C.-Y. and Yu, C.-J. and Shih, J.-Y. and Chang, Y.-L. and Cheng, C.-L. and Hsu, C.-P. and Hsia, J.-Y. and Lin, C.-Y. and Wu, G. and Liu, C.-H. and Wang, C.-D. and Yang, K.-C. and Chen, Y.-W. and Lai, Y.-L. and Hsu, C.-C. and Lin, T.-C. and Yang, T.-Y. and Chen, K.-C. and Hsu, K.-H. and Chen, J.J.W. and Chang, G.-C. and Li, K.-C. and Yang, P.-C.; 袁新盛;俞松良;陳璿宇;許藝瓊;蘇剛毅;陳惠文;陳志毅;余忠仁;施金元;張逸良;楊宗穎;徐中平;楊泮池; Yuan, Shinsheng; Yu, Sung-Liang; Chen, Hsuan-Yu; Hsu, Yi-Chiung; Su, Kang-Yi; Chen, Huei-Wen; Chen, Chih-Yi; Yu, Chong-Jen; Shih, Jin-Yuan; Chang, Yih-Leong; Cheng, Chiou-Ling; Hsu, Chung-Ping; Hsia, Jiun-Yi; Lin, Chien-Yu; Wu, Guani; SUNG-LIANG YU; YIH-LEONG CHANG; Chong-Jen Yu; PAN-CHYR YANG; Chen, Chia-Yen; KANG-YI SU; HUEI-WEN CHEN; JIN-YUAN SHIH; Yuan, Shinsheng; Yu, Sung-Liang; Chen, Hsuan-Yu; Hsu, Yi-Chiung; Su, Kang-Yi; Chen, Huei-Wen; Chen, Chih-Yi; Yu, Chong-Jen; Shih, Jin-Yuan |
| 臺大學術典藏 |
2018-09-10T07:45:28Z |
Detection of EGFR Mutation by High Sensitive MALDI-TOF MS for Predicting EGFR-TKIs Response and Treatment Outcome of Stage ⅢB/Ⅳ Patients
|
Kang-Yi Su;Jin-Yuan Shih;His-Chun Kao;Chu-Chun Hsu;Chien-Yu Lin;Ker-Chao Li;Sung-Liang Yu;Chih-Hsin Yang;Pan-Chyr Yang; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T05:48:16Z |
Decreased expressions of hepsin in human hepatocellular carcinomas
|
YUNG-MING JENG; JIN-CHUAN SHEU; KANG-YI SU; SHU-WHA LIN; Chen, C.-H. and Su, K.-Y. and Tao, M.-H. and Lin, S.-W. and Su, Y.-H. and Tsai, Y.-C. and Cheng, K.-C. and Jeng, Y.-M. and Sheu, J.-C. |
| 臺大學術典藏 |
2018 |
Characteristics and Predictive Value of PD-L1 Status in Real-World NonSmall Cell Lung Cancer Patients
|
Tseng J.-S.; Yang T.-Y.; Wu C.-Y.; Ku W.-H.; Chen K.-C.; Hsu K.-H.; Huang Y.-H.; KANG-YI SU; Yu S.-L.; Chang G.-C.; Tseng J.-S.;Yang T.-Y.;Wu C.-Y.;Ku W.-H.;Chen K.-C.;Hsu K.-H.;Huang Y.-H.;Kang-Yi Su;Yu S.-L.;Chang G.-C. |
| 中國醫藥大學 |
2015-04 |
HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinoma
|
(Chi-Chung Wan);(Kang-Yi Su);(Hsuan-Yu Chen);(So-Yi Chang);(Chi-Fan Shen);謝佳宏(Chia-Hung Hsieh);(Qi-Sheng Hong);(Ching-Cheng Chiang);(Gee-Chen Chang);(Sung-Liang Yu);(Jeremy J.W. Chen) |
| 中國醫藥大學 |
2015-03 |
Identification of Five Driver Gene Mutationsin Patients with Treatment-Na?ve Lung Adenocarcinoma in Taiwan
|
(Kuo-Hsuan Hsu);(Chao-Chi Ho);夏德椿(Te-Chun Hsia);(Jeng-Sen Tseng);(Kang-Yi Su);(Ming-Fang Wu);(Kuo-Liang Chiu);(Tsung-Ying Yang);(Kun-Chieh Chen);(Hean Ooi)* |
| 臺大學術典藏 |
2013 |
Potential therapeutic role of hispidulin in gastric cancer through induction of apoptosis via NAG-1 signaling
|
Yu, C.Y. and Su, K.-Y. and Lee, P.-L. and Jhan, J.-Y. and Tsao, P.-H. and Chan, D.-C. and Chen, Y.-L.S.; KANG-YI SU |
| 中國醫藥大學 |
2011-09 |
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations.
|
(Shinsheng Yuan);(Sung-Liang Yu);(Hsuan-Yu Chen);(Yi-Chiung Hsu);(Kang-Yi Su);(Huei-Wen Chen);陳志毅(Chih-Yi Chen);(Chong-Jen Yu);(Jin-Yuan Shih);(Yih-Leong Chang);(Chiou-Ling Cheng);(Chung-Ping Hsu);(Jiun-Yi Hsia);(Chien-Yu Lin);(Guani Wu);(Chia-Hsin Liu);(Chin-Di Wang);(Kang-Chung Yang);(Yi-Wei Chen);(Yi-Ling Lai);(Chu-Chun Hsu);(Tai-Ching Lin);(Tsung-Ying Yang);(Kun-Cheieh Chen);(Kuo-Hsuan Hsu);(Jeremy J.W. Chen);(Gee-Chen Chang);(Ker-Chau Li);(Pan-Chyr Yang)* |
| 中國醫藥大學 |
2011-04 |
Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.
|
(Tzu-Hua Chan); (Meng-Feng Tsai); (Kang-Yi Su); (Shang-Gin Wu); (Cheng-Po Huang); (Sung-Liang Yu); 余永倫(Yung-Luen Yu); (Chou-Chin Lan); (Chih-Hsin Yang); (Shwu-Bin Lin); (Chin-Pyng Wu); (Jin-Yuan Shih); (Pan-Chyr Yang)* |
顯示項目 66-85 / 85 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
